Milusheva, M.; Todorova, M.; Gledacheva, V.; Stefanova, I.; Feizi-Dehnayebi, M.; Pencheva, M.; Nedialkov, P.; Tumbarski, Y.; Yanakieva, V.; Tsoneva, S.;
et al. Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals 2023, 16, 1660.
https://doi.org/10.3390/ph16121660
AMA Style
Milusheva M, Todorova M, Gledacheva V, Stefanova I, Feizi-Dehnayebi M, Pencheva M, Nedialkov P, Tumbarski Y, Yanakieva V, Tsoneva S,
et al. Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals. 2023; 16(12):1660.
https://doi.org/10.3390/ph16121660
Chicago/Turabian Style
Milusheva, Miglena, Mina Todorova, Vera Gledacheva, Iliyana Stefanova, Mehran Feizi-Dehnayebi, Mina Pencheva, Paraskev Nedialkov, Yulian Tumbarski, Velichka Yanakieva, Slava Tsoneva,
and et al. 2023. "Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases" Pharmaceuticals 16, no. 12: 1660.
https://doi.org/10.3390/ph16121660
APA Style
Milusheva, M., Todorova, M., Gledacheva, V., Stefanova, I., Feizi-Dehnayebi, M., Pencheva, M., Nedialkov, P., Tumbarski, Y., Yanakieva, V., Tsoneva, S., & Nikolova, S.
(2023). Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals, 16(12), 1660.
https://doi.org/10.3390/ph16121660
